TC BioPharm (Holdings) plc American Depositary Shares
TCBP
TCBP was delisted on the 21st of March, 2025.
11 hedge funds and large institutions have $646K invested in TC BioPharm (Holdings) plc American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
83% more funds holding
Funds holding: 6 → 11 (+5)
70% more capital invested
Capital invested by funds: $380K → $646K (+$266K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$13.2K |
| 2 |
CAG
Csenge Advisory Group
Clearwater,
Florida
|
+$13.2K |
| 3 |
MWM
Modera Wealth Management
Westwood,
New Jersey
|
+$8.26K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$6.61K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$6.61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$119K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$33K |
| 3 |
Renaissance Technologies
New York
|
-$31.4K |
| 4 |
VF
Virtu Financial
New York
|
-$6K |
TCBP Hedge Fund Activity: Q3 2023 in Review
11 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc American Depositary Shares (TCBP) for Q3 2023, worth a combined $646K — up 70% from $380K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TCBP positions and 1 closed out — a net gain of 5 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Cresset Asset Management, opening a new position worth an estimated $13.2K. The largest seller was Armistice Capital, cutting an estimated $119K.
- 11 institutional investors held TC BioPharm (Holdings) plc American Depositary Shares (TCBP) as of Q3 2023, up from 6 in Q2 2023.
- Funds reported $646K of TC BioPharm (Holdings) plc American Depositary Shares stock for Q3 2023, up 70% quarter-over-quarter.
- 6 funds opened new TC BioPharm (Holdings) plc American Depositary Shares positions in Q3 2023 and 1 closed out, a net change of +5 holders.
- The largest TC BioPharm (Holdings) plc American Depositary Shares buyer in Q3 2023 was Cresset Asset Management, an estimated $13.2K added.
- The largest TC BioPharm (Holdings) plc American Depositary Shares seller in Q3 2023 was Armistice Capital, an estimated $119K sold.
Based on aggregated 13F filings for Q3 2023.